StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) stock

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.69−0.23 (-0.82%)

Close on Nov 18, 2026Market cap $1.23BP/E –Yield –

Avalyn Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Avalyn Pharma

Avalyn Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Avalyn Pharma figures

See a number that looks wrong?